Evidence-Based Precision Oncology with the Cancer Targetome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evidence-Based Precision Oncology with the Cancer Targetome

Published:2017-12 Issue:12 Volume:38 Page:1085-1099
ISSN:0165-6147
Container-title:Trends in Pharmacological Sciences
language:en
Short-container-title:Trends in Pharmacological Sciences

Author:

Blucher Aurora S.,Choonoo Gabrielle,Kulesz-Martin Molly,Wu Guanming,McWeeney Shannon K.

Funder

National Library of Medicine Informatics Training

National Cancer Institute

National Human Genome Research Institute

National Center for Advancing Translational Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Toxicology

Reference74 articles.

1. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia;Druker;N. Engl. J. Med.,2001

2. Precision oncology: origins, optimism, and potential;Prasad;Lancet Oncol.,2016

3. What precisely is precision oncology – and will it work?;Prasad;ASCO Post,2017

4. Precision medicine needs randomized clinical trials;Saad;Nat. Rev. Clin. Oncol.,2017

5. Prioritizing targets for precision cancer medicine;Andre;Ann. Oncol.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Docetaxel targets aggressive methylation profiles and serves as a radiosensitizer in high-risk meningiomas;Neuro-Oncology;2022-08-17

2. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia;Cancer Cell;2022-08

3. Cell Surface Markers and their Targeted Drugs in Breast Cancer;Current Protein & Peptide Science;2022-05

4. Functional proteomics of patient derived head and neck squamous cell carcinoma cells reveal novel applications of trametinib;Cancer Biology & Therapy;2022-03-28

5. Integrated Genomic Profiling and Drug Screening of Patient-Derived Cultures Identifies Individualized Copy Number-Dependent Susceptibilities Involving PI3K Pathway and 17q Genes in Neuroblastoma;Frontiers in Oncology;2021-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3